TABLE 1.
Characteristics | Training group (n = 224) | Testing group (n = 95) | Entire group (n = 319) | P-value |
Age (year) | ||||
≤60 | 113 | 47 | 160 | 0.987 |
>60 | 111 | 48 | 159 | |
Gender | ||||
Male | 156 | 63 | 219 | 0.842 |
Female | 58 | 32 | 100 | |
Tumor grade | ||||
G1 | 31 | 13 | 44 | 0.456 |
G2 | 117 | 37 | 154 | |
G3 | 68 | 41 | 109 | |
G4 | 8 | 4 | 12 | |
Clinical stage | ||||
I | 118 | 42 | 160 | 0.66 |
II | 48 | 28 | 76 | |
III | 55 | 25 | 80 | |
IV | 3 | 0 | 3 |